Brad Walsh has resigned from the Australian Proteomics Analysis Facility in Sydney, where he served as facilities manager, Walsh told ProteoMonitor. He did not comment on his future plans, except to say that “in a short time I will have a nice end to the story.”

Henry Nowak has joined Caprion Pharmaceuticals as chief financial officer and executive vice president for legal affairs, Montreal-based Caprion said last week.